Digital Management Systems in Academic Health Sciences Laboratories: A Scoping Review.

Good laboratory practices (GLP) increase the quality and traceability of results in health sciences research. However, factors such as high staff turnover, insufficient resources, and a lack of training for managers may limit their implementation in research and academic laboratories. This Scoping Review aimed to identify digital tools for managing academic health sciences and experimental medicine laboratories and their relationship with good practices. Following the PRISMA-ScR 2018 criteria, a search strategy was conducted until April 2021 in the databases PUBMED, Web of Sciences, and Health Virtual Library. A critical appraisal of the selected references was conducted, followed by data charting. The search identified twenty-one eligible articles, mainly originated from high-income countries, describing the development and/or implementation of thirty-two electronic management systems. Most studies described software functionalities, while nine evaluated and discussed impacts on management, reporting both improvements in the workflow and system limitations during implementation. In general, the studies point to a contribution to different management issues related to GLP principles. In conclusion, this review identified evolving evidence that digital laboratory management systems may represent important tools in compliance with the principles of good practices in experimental medicine and health sciences research.

Uncaria tomentosa in the treatment of the herpes labialis: randomized double-blind trial / Uncaria tomentosa no tratamento de herpes labial: estudo duplo-cego randomizado

Introduction: the lesions caused by herpes simplex are common and have symptoms affecting the quality of life of affected people. Objective: this study aims to assess the safety efficacy of cream with Uncaria tomentosa (cat?s claw), for topical treatment of the herpes labialis. Methods: a clinical investigation was undertaken by means of controlled, randomized, double-blinded protocol in humans. According to the regulatory procedures, 74 patients were selected based on inclusion/exclusion criteria previously submitted to the Local Ethical Committee (no 144/02) whenever herpes labialis lesion appeared. Following, those selected through medical evaluation received either the test (Uncaria) or the reference (Acyclovir) drug. Results: fifty-four episodes of herpes labialis lesions ecloded in 31 volunteers. After their clinical assessment, one showed 4 episodes, two had 3 episodes and six had 2 infections. Hence, 27 patients received the reference drug while 27 applied the Uncaria cream four times a day. Overall, there were not significant differences between either responses. Although, the Uncaria group showed lower scores on the first two days of treatment (p < 0,005; t = 0,028), on day 3, it was even to Acyclovir. Conclusion:the assessment of clinical efficacy of either treatment demonstrated that both drugs were safe as no adverse reactions were reported. Futher, there was no difference (p > 0,05) in the overall period infections as well as in the inflammatory process or crost formation. Regarding the severity of inflammatory reaction, the clinical efficacy of Uncaria tomentosa was significantly better than acyclovir. Rather than the being antiviral drug, the Uncaria tomentosa may act as an anti-inflammatory agent and this would possibly represent an advantage of not inducing viral resistance for long use.

Introdução: as lesões causadas por herpes simples são comuns e apresentam sintomatologia que altera a qualidade de vida das pessoas acometidas. Objetivo: este estudo visa avaliar a eficácia da segurança de creme com Uncaria tomentosa (unha-de-gato) para o tratamento tópico de herpes labial. Métodos: a pesquisa clínica foi realizada por meio de protocolo controlado, randomizado e duplo-cego. De acordo com os procedimentos de regulamentação, 74pacientes foram selecionados com base em critérios de inclusão e exclusão previamente submetidos à Comissão de Ética Local (no 144/02), sempre a lesão de herpes labial apareceu. Em seguida, os selecionados através de avaliação médica receberam o produto-teste (Uncaria) ou o de referência (aciclovir).Resultados: cinquenta e quatro episódios de lesões de herpes labial eclodiram em 31 voluntários. Após a avaliação clínica, um apresentou quatro episódios, dois tiveram três episódios e seis tinham duas infecções. Assim, 27 pacientes receberam a droga de referência, enquanto 27 aplicaram o creme Uncaria quatro vezes por dia. Em geral, não houve diferença significativa entre as respostas. Contudo, o grupo de Uncaria apresentou escores inferiores nos dois primeiros dias de tratamento (p < 0,005 t = 0,028), depois do dia 3, foi similar ao aciclovir. Conclusão: a avaliação da eficácia clínica dos tratamentosdemonstraram que ambas as drogas foram seguras, bem como não foram notificadas reações adversas. Além disso, não houve diferença significativa (p 0,05) no período total de infecções, bem como no processo inflamatório ou na formação de crosta. Quanto à gravidade da reação inflamatória, a eficácia clínica da Uncaria tomentosa foi significativamente melhor do que o aciclovir. Em vez de a droga ser antiviral, a Uncaria tomentosa pode atuar como um agente anti-inflamatório e isso, possivelmente, representa uma vantagem de não induzir resistência viral para uso por muito tempo.

Experimental models using radionuclides for assessment of the effects of natural drugs

The aim of this study was to evaluate the effect of the extracts of Nectandra membranacea (N. membranacea), Ginkgo biloba (EGb) and Passiflora (PEF) on the morphology of red blood cells (RBC), on the biodistribution of sodium pertechnetate (99mTcO4Na), on the morphology of duodenum and on the labeling of blood constituents (BC, IF-P, IF-BC) with technetium-99m (Tc-99m). Morphometry studies also were performed. The results show that EGb promotes alteration of the labeling of BC, IF-P and IF-BC (p<0.05). The N. membranacea extract does not promote significant alteration of the radiolabeling, and PEF extract alters the IF-P labeling. N. membranacea, EGb and PEF extracts were able to alter the RBC morphology (P<0.05). N. membranacea extract and EGb modifies the biodistribution of the 99mTcO4Na, and EGb influences the morphometry of duodenum isolated from rats (P<0.05).

O objetivo deste estudo foi avaliar o efeito de um extrato de Nectandra (N. membranacea), de Ginkgo (EGb) e de Passiflora e. flavicarpa (PEF) na marcação de constituintes sanguíneos (BC, IF-P, IF-BC) com Tc-99m, na morfologia de hemácias (RBC), na biodistribuição do 99mTcO4Na na morfologia do duodeno. Amostras de sangue foram incubadas com os extratos. Tc-99m foi adicionado e as frações do plasma (IF-P) e da célula (IF-BC) foram isoladas. Estudos morfométricos foram realizados. Os resultados mostram que EGb promove alteração na marcação de BC, IF-P e IF-BC. N. membranacea não altera a radiomarcação e PEF altera a marcação de IF-P. O extrato de N. membranacea, EGb e PEF alteraram a morfologia de RBC (p<0.05). Os extratos de N. membranacea e EGb modificam a biodistribuição do 99mTcO4Na, e o EGb influencia a morfometria (p<0.05) do duodeno de ratos.

Ultrastructural analysis of kidney, liver and duodenum isolated from treated rats with Ginkgo Biloba extract and effects of this medicinal plant on the biodistribution of the padiopharmaceutical sodium pertechnetate

Ginkgo biloba extract (EGb) has been used to treat memory and concentration deficits, acts as platelet activatingfactor antagonism and prevents against damages caused by free radicals. EGb is a standardized extract that contains 24% flavonoids and 6% terpenoids. The aim of this work was to evaluate the possible influence of an EGb on the ultrastructure of some organs isolated from rats and on the biodistribution of sodium pertechnetate (99mTcO4Na). The animals were treated with EGb and after six days, received 99mTcO4Na. The organs were isolated and fixed for ultrastructural analysis. The results showed that EGb has modified the ultrastructure of kidney, liver and duodenum and altered the biodistribution of 99mTcO4Na (P<0.05). It is speculated that the substances present in the EGb could act directly or generate metabolites capable to promote changes on the biodistribution of 99mTcO4Na and on the morphology of organs at ultrastructural level.

O extrato de Ginkgo Biloba extract (EGb) tem sido usado para tratar dificuldades de concentração,memória, age como antagonista do fator de ativação de plaquetas e previne contra danos causados por radicais livres. EGb é um extrato padronizado com 24% de flavonóides e 6% de lactonas terpênicas. O objetivo deste estudo foi avaliar o efeito de um EGb na ultraestrutura de alguns órgãos isolados de ratos e na biodistribuição do radiofármaco pertecnetato de sódio (99mTcO4Na). Os animais foram tratados com EGb e após 6 dias receberam 99mTcO4Na. Os órgãos foram isolados e a radioatividadedeterminada. Os tecidos foram fixados para microscopia eletrônica. Os resultados mostraram que EGb alterou a ultraestrutura do rim, figado e duodeno e modificou a biodistribuição do99mTcO4Na. Sugerimos que substâncias presentes no EGb poderiam agir diretamente ou gerar metabólitos capazes de promover alterações nabiodistribuição e na morfologia de órgãos em nível ultraestrutural.

Estudo de bioequivalência da clozapina em pacientes psicóticos no estado de equilíbrio / Bioequivalence study of clozapine in psychotic patients at steady state

Clozapina é um derivado dibenzodiazepinico, triciclico, com potentes propriedades antipisicóticas. tem baixa afinidade por receptores D2 e, por isso, não produz significativa síndrome extrapiramidal, típica dos principais fármacos nessa categoria, sendo então, considerado como um neuroléptico atípico. É eficaz em pacientes esquizofrênicos refratários ou intolerantes à terapêutica antipsicótica clássica...Todos os pacientes toleraram bem as duas formulações de Clozapina. Nenhum efeito adverso sério foi relatado. Todos os parâmetros farmacocinéticos calculados no ´presente estudo foram bastante semelhantes quando comparados teste e referência. O intervalo de confiança 90% para as médias geométrica das razões de InCmax (0,9677 - 0,9937) e InASC 0-12h (0,9811-1.0029) estava dentro do intervalo de bioequivalência (0,80 a 1,25), segundo orientações da ANVISA e aceito pelos padrões regulatórios internacionais. Os resultados demonstraram que a formulação Teste (Zolapin) foi bioequivalente à formulação Referência (Leponex) quando administrada por via oral em pacientes esquizofrênicos, ambos em termos da taxa e extensão da absorção, podendo ser intercambiável.

The ingestion of a Nectandra membranacea extract changes the bioavailability of technetium-99m radiobiocomplex in rat organs.

The radiobiocomplexes labeled with technetium-99m (Tc-99m) have been widely used in nuclear medicine in single photon emission computed tomography and in basic research. The aim of this study was to assess the influence of a Nectandra membranacea extract on the bioavailability of the sodium pertechnetate (Na(99m)TcO(4)) radiobiocomplex in rat organs. The animals were treated with a N. membranacea extract (30 mg/ ml), for 6 days. Na(99m)TcO(4) was injected, the organs were isolated and weighed, and the radioactivity was determined in each organ (%ATI/organ). The %ATI/organ was divided by the mass of each organ to calculate the %ATI/g. A significant increase of the %ATI/organ of Na(99m)TcO(4) was observed in muscle and thyroid as well as in the %ATI/g in the heart, kidney and thyroid. These findings could result from the interaction between components of the plant extract and the radiobiocomplex which may influence the uptake Na(99m)TcO(4) in rat organs. Therefore, precaution is suggested in the interpretation of nuclear medicine results in patients using this herb.

The ingestión of a Nectandra membran cea extract changes the bioavailability of technetium-99m radiobiocomplex in rat organs

The radiobiocomplexes labeled with technetium-99m (Tc-99m) have been widely used in nuclear medicine in single photon emission computed tomography and in basic research. The aim of this study was to assess the influence of a Nectandra membran cea extract on the bioavailability of the sodium pertechnetate (Na99mTc0(4)) radiobiocomplex in rat organs. The animals were treated with a N. membran cea extract (30 mg/ ml), for 6 days. Na99mTc0(4) was injected, the organs were isolated and weighed, and the radioactivity was determined in each organ ( percentATI/organ). The percentATI/organ was divided by the mass of each organ to calculate the percentATI/g. A significant increase of the percentATI/organ of Na99mTc0(4) was observed in muscle and thyroid as well as in the percentATI/g in the heart, kidney and thyroid. These findings could result from the interaction between components of the plant extract and the radiobiocomplex which may influence the uptake Na99mTc0(4) in rat organs. Therefore, precaution is suggested in the interpretation of nuclear medicine results in patients using this herb.